Supera Anesthesia Innovations Announces the OC6200 - WICU12/WSEE Erie, PA News, Sports, Weather and Events

Supera Anesthesia Innovations Announces the OC6200

This article was originally distributed via PRWeb. PRWeb, WorldNow and this Site make no warranties or representations in connection therewith.

SOURCE: The Oakmont Group

New product allows users to convert VMS MATRX veterinary anesthesia equipment to a money-saving oxygen concentrator without fully replacing existing equipment; is the latest offering in the Pureline™ brand of products.

Portland, Oregon (PRWEB) January 16, 2013

Supera Anesthesia Innovations, inventor of the Pureline™ brand of oxygen concentrators for use in veterinary anesthesia, announces the release of the Pureline™ OC6200. The latest offering from Supera Anesthesia Innovations under the Pureline™ brand of products allows veterinary professionals to convert VMS MATRX and LEI Medical/Supera M1200 veterinary anesthesia equipment to a money-saving oxygen concentrator model quickly and easily.

Supera Anesthesia Innovations, formerly LEI Medical, manufactures and supplies high quality equipment to the veterinary industry and has been in business since 1993.

Supera Anesthesia Innovations’ new Pureline™ OC6200 offers customers the opportunity to stop paying for tanks, refills and deliveries by utilizing the energy and money saving features that come standard on this model. Other features include:

•     18” square footprint to save space
•     Super-sturdy construction
•     Includes free “E” tank
•     Premium-quality manufacturing
•     Low center of gravity for extreme stability
•     Easy on/off; controls are large and easily accessible
•     Audible and illuminated safety alerts
•     Quiet 40-dBA operation
•     3-in. heavy-duty locking casters
•     Large shelf with additional storage features
•     Made in the USA; ships direct from Portland, Oregon facility

“We’re always looking for ways to make our technology function better for our customers,” says Brian Lawson, President and Founder of Supera Anesthesia Innovations. “With the OC6200, we’re really met the demands of our customers and listened to their feedback. We feel confident that once people make the switch to the Pureline™ products, they will understand the value of both quality and cost savings that these machines are going to deliver for their practice.”

Supera Anesthesia Innovations, the countries leading innovator in designing oxygen concentrator technology for veterinary anesthesia applications, also has numerous other products in the works, which will be announced soon. All Supera Anesthesia Innovations products are 100% American made and ship directly from the Supera Anesthesia Innovations facility outside of Portland, Oregon. To learn more, please visit http://www.superavet.com. Product photos available on request.

Pureline™ Oxygen Concentrators:
Supera Anesthesia Innovations is proud to present a revolutionary new line of oxygen concentrator technologies for veterinary anesthesia here in the U.S. for the first time. While similar machines have been in use in Europe for years, Supera Anesthesia Innovations has perfected the technology, added safety features, and now is making this money-saving equipment available here. The built-in E-tank manifold on the M6000 and OC6000 models allows mobile use of the machine without power.                        

About Supera Anesthesia Innovations:
Supera Anesthesia Innovations is a Portland, Oregon based company and the countries leading innovator of oxygen concentrator technology for veterinary anesthesia applications. Since 1993, Supera Anesthesia Innovations has consistently improved the safety and quality of veterinary medical equipment. Supera Anesthesia Innovations designs and manufactures high-quality, precision anesthesia machines, stands, wall mounts, tabletops, vaporizer products, medical gas, suction and oxygen delivery products. For more information on Supera Anesthesia Innovations, please call 877-620-1500 or visit http://www.superavet.com

###

For the original version on PRWeb visit: http://www.prweb.com/releases/prweb2013/1/prweb10324240.htm